Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. [electronic resource]
Producer: 20010426Description: 662-7 p. digitalISSN:- 0002-9378
- Anemia, Iron-Deficiency -- blood
- Erythrocyte Count
- Erythrocyte Indices
- Erythropoietin -- administration & dosage
- Female
- Ferric Compounds -- administration & dosage
- Ferric Oxide, Saccharated
- Ferritins -- blood
- Fetal Growth Retardation -- complications
- Glucaric Acid
- Hematocrit
- Humans
- Placental Insufficiency -- complications
- Pregnancy
- Pregnancy Complications -- drug therapy
- Pregnancy Outcome
- Recombinant Proteins
- Reticulocyte Count
- Transferrin -- analysis
- Treatment Outcome
- Ultrasonography
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.